Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ProKidney Corp. - Class A Ordinary Shares (NQ: PROK ) 2.390 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about ProKidney Corp. - Class A Ordinary Shares < Previous 1 2 Next > ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S. September 03, 2024 From ProKidney Via GlobeNewswire ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference August 27, 2024 From ProKidney Via GlobeNewswire ProKidney Reports Business Updates and Second Quarter 2024 Financial Results August 09, 2024 From ProKidney Via GlobeNewswire ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option June 17, 2024 From ProKidney Via GlobeNewswire ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering June 11, 2024 From ProKidney Via GlobeNewswire ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering June 10, 2024 From ProKidney Via GlobeNewswire ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates June 10, 2024 From ProKidney Via GlobeNewswire ProKidney to Participate in the Jefferies Global Healthcare Conference May 29, 2024 From ProKidney Via GlobeNewswire ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 May 21, 2024 From ProKidney Via GlobeNewswire ProKidney Reports Business Updates and First Quarter 2024 Financial Results May 10, 2024 From ProKidney Via GlobeNewswire ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations March 25, 2024 From ProKidney Via GlobeNewswire ProKidney to Participate in Jefferies Biotech on the Bay Summit February 29, 2024 From ProKidney Via GlobeNewswire ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer November 30, 2023 Former CEO of Africa Healthcare Network brings extensive understanding of kidney disease to ProKidney From ProKidney Via GlobeNewswire ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference November 21, 2023 From ProKidney Via GlobeNewswire ProKidney Reports Third Quarter Financial Results November 14, 2023 From ProKidney Via GlobeNewswire ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates November 13, 2023 From ProKidney Via GlobeNewswire ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023 October 30, 2023 Total of 6 abstracts accepted for publication in Kidney Week 2023 program From ProKidney Via GlobeNewswire ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference September 05, 2023 From ProKidney Via GlobeNewswire ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights August 10, 2023 From ProKidney Via GlobeNewswire ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC July 18, 2023 From ProKidney Via GlobeNewswire ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization July 17, 2023 From ProKidney Via GlobeNewswire ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC June 13, 2023 From ProKidney Via GlobeNewswire ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference June 01, 2023 From ProKidney Via GlobeNewswire ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights May 11, 2023 From ProKidney Via GlobeNewswire ProKidney to Present at the BofA Securities Health Care Conference 2023 May 04, 2023 From ProKidney Via GlobeNewswire ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights March 28, 2023 From ProKidney Via GlobeNewswire ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference March 03, 2023 From ProKidney Via GlobeNewswire ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease January 10, 2023 From ProKidney Via GlobeNewswire ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights November 14, 2022 From ProKidney Via GlobeNewswire ProKidney to Participate in Upcoming Investor Conferences November 11, 2022 From ProKidney Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.